From: Role of mitral valve repair in active infective endocarditis: long term results
Parameter | Preoperative | Follow up | |
---|---|---|---|
LV Ejection fraction (%) | |||
> 50% | 26 | 29 | |
35–50% | 4 | 0 | χ 2 5.472 |
< 35% | 4 | 0 | p 0.065 |
Pulmonary systolic pressure (mmHg) | |||
> 50 mmHg | 6 | 0 | |
30–50 mmHg | 19 | 14 | χ2 7.264 |
< 30 mmHg | 9 | 15 | p 0.0265 |
LV end diastolic diameter (mm) | |||
< 55 mm | 17 | 24 | |
55–60 mm | 3 | 5 | χ2 16.92 |
> 60 mm | 14 | 0 | p 0.0002 |
Mitral regurgitation | |||
0 | 0 | 9 | |
< 2+ | 4 | 20 | χ2 47.57 |
3+ 4+ | 30 | 0 | p < 0.0001 |
NYHA functional class | |||
I | 3 | 17 | |
II | 9 | 10 | χ2 25.69 |
III | 17 | 2 | p < 0.0001 |
IV | 5 | 0 |